These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6420144)

  • 1. Stereoselectivity of the arene epoxide pathway of mephenytoin hydroxylation in man.
    Küpfer A; Lawson J; Branch RA
    Epilepsia; 1984 Feb; 25(1):1-7. PubMed ID: 6420144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mephenytoin hydroxylation deficiency: kinetics after repeated doses.
    Küpfer A; Desmond P; Patwardhan R; Schenker S; Branch RA
    Clin Pharmacol Ther; 1984 Jan; 35(1):33-9. PubMed ID: 6690169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective mephobarbital hydroxylation cosegregates with mephenytoin hydroxylation.
    Küpfer A; Branch RA
    Clin Pharmacol Ther; 1985 Oct; 38(4):414-8. PubMed ID: 4042524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A major pathway of mephenytoin metabolism in man. Aromatic hydroxylation to p-hydroxymephenytoin.
    Küpfer A; Brilis GM; Watson JT; Harris TM
    Drug Metab Dispos; 1980; 8(1):1-4. PubMed ID: 6102023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective metabolism and pharmacogenetic control of 5-phenyl-5-ethylhydantoin (nirvanol) in humans.
    Küpfer A; Patwardhan R; Ward S; Schenker S; Preisig R; Branch RA
    J Pharmacol Exp Ther; 1984 Jul; 230(1):28-33. PubMed ID: 6747829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of hydroxylated and demethylated metabolites of mephenytoin in man and laboratory animals using gas-liquid chromatography and high-performance liquid chromatography.
    Küpfer A; James R; Carr K; Branch R
    J Chromatogr; 1982 Oct; 232(1):93-100. PubMed ID: 7142342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in man.
    Küpfer A; Preisig R
    Eur J Clin Pharmacol; 1984; 26(6):753-9. PubMed ID: 6489416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic differences in mephenytoin pharmacokinetics in normal subjects.
    Wedlund PJ; Aslanian WS; Jacqz E; McAllister CB; Branch RA; Wilkinson GR
    J Pharmacol Exp Ther; 1985 Sep; 234(3):662-9. PubMed ID: 4032286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphic metabolism of mephenytoin in man: pharmacokinetic interaction with a co-regulated substrate, mephobarbital.
    Jacqz E; Hall SD; Branch RA; Wilkinson GR
    Clin Pharmacol Ther; 1986 Jun; 39(6):646-53. PubMed ID: 3709029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereochemistry of aromatic phenytoin hydroxylation in various drug hydroxylation phenotypes in humans.
    Fritz S; Lindner W; Roots I; Frey BM; Küpfer A
    J Pharmacol Exp Ther; 1987 May; 241(2):615-22. PubMed ID: 3572817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assay of mephenytoin metabolism in human liver microsomes by high-performance liquid chromatography.
    Meier UT; Kronbach T; Meyer UA
    Anal Biochem; 1985 Dec; 151(2):286-91. PubMed ID: 4096368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative metabolism of hexobarbital in human liver: relationship to polymorphic S-mephenytoin 4-hydroxylation.
    Knodell RG; Dubey RK; Wilkinson GR; Guengerich FP
    J Pharmacol Exp Ther; 1988 Jun; 245(3):845-9. PubMed ID: 3385644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new oxidative drug metabolism polymorphism.
    Wedlund PJ; Aslanian WS; McAllister CB; Wilkinson GR; Branch RA
    Clin Pharmacol Ther; 1984 Dec; 36(6):773-80. PubMed ID: 6499356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between mephenytoin oxidation polymorphism and phenytoin, methylphenytoin and phenobarbitone hydroxylation assessed in a phenotyped panel of healthy subjects.
    Schellens JH; van der Wart JH; Breimer DD
    Br J Clin Pharmacol; 1990 Jun; 29(6):665-71. PubMed ID: 2378787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of R-enantiomeric normephenytoin during chronic administration in epileptic patients.
    Bourgeois BF; Küpfer A; Wad N; Egli M
    Epilepsia; 1986; 27(4):412-8. PubMed ID: 3720699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for the epoxide-diol pathway in the biotransformation of mephenytoin.
    Gerber N; Thompson RM; Smith RG; Lynn RK
    Epilepsia; 1979 Jun; 20(3):287-94. PubMed ID: 446437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mephenytoin hydroxylation polymorphism: characterization of the enzymatic deficiency in liver microsomes of poor metabolizers phenotyped in vivo.
    Meier UT; Dayer P; Malè PJ; Kronbach T; Meyer UA
    Clin Pharmacol Ther; 1985 Nov; 38(5):488-94. PubMed ID: 4053486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mephenytoin hydroxylation in the Cuna Amerindians of Panama.
    Inaba T; Jorge LF; Arias TD
    Br J Clin Pharmacol; 1988 Jan; 25(1):75-9. PubMed ID: 3370193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular mechanisms of two common polymorphisms of drug oxidation--evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation.
    Meyer UA; Gut J; Kronbach T; Skoda C; Meier UT; Catin T; Dayer P
    Xenobiotica; 1986 May; 16(5):449-64. PubMed ID: 2874666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of mephenytoin, 4-hydroxymephenytoin and 4-hydroxyphenytoin enantiomers in human urine by cyclodextrin micellar electrokinetic capillary chromatography: simple determination of a hydroxylation polymorphism in man.
    Desiderio C; Fanali S; Küpfer A; Thormann W
    Electrophoresis; 1994 Jan; 15(1):87-93. PubMed ID: 8143685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.